全球单细胞体学市场规模、份额、趋势和成长分析报告（2026-2034）

单细胞体学市场预计将从 2025 年的 28.5 亿美元成长到 2034 年的 111.5 亿美元，2026 年至 2034 年的复合年增长率为 16.36%。

随着全球对精准医疗和先进基因组学研究的日益关注，全球单细胞体学市场正经历强劲成长。研究人员越来越多地采用单细胞定序技术来了解细胞异质性，尤其是在肿瘤学、免疫学和神经病学领域。生物技术研究投入的增加、基因体学计划经费的扩大以及慢性病盛行率的上升，都在推动市场需求。学术机构和製药公司正在加速合作，以利用高解析度细胞分析技术开发标靶治疗。

关键成长要素包括次世代定序(NGS) 技术的进步、生物资讯整合以及实验室工作流程的自动化。定序成本的降低和单细胞 RNA定序平台的扩展进一步提升了市场渗透率。製药公司正在利用单细胞体学的日益广泛应用，也使其应用范围扩展到多个治疗领域。

展望未来，人工智慧驱动的数据分析和多组体学整合平台能够提供更深入的生物学见解，有望推动市场发展。新兴经济体正大力投资生命科学基础设施，开启新的成长路径。策略合作、产品创新和不断扩大的临床研究活动将继续塑造竞争格​​局。随着个人化医疗成为现代医疗保健体系的核心支柱，全球单细胞体学市场预计将持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球单细胞体学市场：依产品类型划分

• 市场分析、洞察与预测
• 单细胞基因体学
• 单细胞转录组学
• 单细胞蛋白质体学
• 单细胞代谢体学

第五章：全球单细胞体学市场：依应用划分

• 市场分析、洞察与预测
• 肿瘤学
• 细胞生物学
• 神经病学
• 免疫学

第六章 全球单细胞体学市场：依最终用户划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 学术研究机构
• 医院/诊断检查室
• 其他的

第七章 全球单细胞体学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • CYTENA GmbH
  • 10x Genomics Inc
  • Becton
  • Dickinson And Company（BD）
  • Cellenion SASU
  • PerkinElmer Inc
  • ANGLE Plc
  • Illumina Inc
  • Bio-Rad Laboratories Inc
  • Mission Bio Inc
  • Standard BioTools Inc

The Single-cell Omics Market size is expected to reach USD 11.15 Billion in 2034 from USD 2.85 Billion (2025) growing at a CAGR of 16.36% during 2026-2034.

The Global Single-cell Omics Market is witnessing strong momentum as precision medicine and advanced genomic research gain global traction. Researchers are increasingly adopting single-cell sequencing technologies to understand cellular heterogeneity, particularly in oncology, immunology, and neurology studies. Rising investments in biotechnology research, expanding funding for genomics projects, and the growing prevalence of chronic diseases are fueling demand. Academic institutes and pharmaceutical companies are accelerating collaborations to leverage high-resolution cellular analysis for targeted therapeutic development.

Key growth drivers include advancements in next-generation sequencing (NGS), bioinformatics integration, and automation in laboratory workflows. The declining cost of sequencing technologies and the expansion of single-cell RNA sequencing platforms are further supporting market penetration. Pharmaceutical firms are utilizing single-cell omics to improve drug discovery pipelines and reduce clinical trial failures. Moreover, increased adoption in regenerative medicine and stem cell research is expanding application scope across multiple therapeutic areas.

Looking ahead, the market is expected to benefit from AI-powered data analytics and multi-omics integration platforms that provide deeper biological insights. Emerging economies are investing heavily in life sciences infrastructure, creating new growth avenues. Strategic partnerships, product innovations, and expanding clinical research activities will continue shaping competitive dynamics. The Global Single-cell Omics Market is poised for sustained expansion as personalized medicine becomes a central pillar of modern healthcare systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Single-Cell Genomics
• Single-Cell Transcriptomics
• Single-Cell Proteomics
• Single-Cell Metabolomics

By Application

• Oncology
• Cell Biology
• Neurology
• Immunology

By End-User

• Pharmaceutical & Biotechnology Companies
• Academic and Research Organizations
• Hospital and Diagnostic Laboratories
• Others

COMPANIES PROFILED

• CYTENA GmbH, 10x Genomics Inc, Becton, Dickinson and Company BD, Cellenion SASU, PerkinElmer Inc, ANGLE plc, Illumina Inc, BioRad Laboratories Inc, Mission Bio Inc, Standard BioTools Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SINGLE-CELL OMICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Single-Cell Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Single-Cell Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Single-Cell Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Single-Cell Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SINGLE-CELL OMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cell Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SINGLE-CELL OMICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospital and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SINGLE-CELL OMICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SINGLE-CELL OMICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 CYTENA GmbH
  • 9.2.2 10x Genomics Inc
  • 9.2.3 Becton
  • 9.2.4 Dickinson And Company (BD)
  • 9.2.5 Cellenion SASU
  • 9.2.6 PerkinElmer Inc
  • 9.2.7 ANGLE Plc
  • 9.2.8 Illumina Inc
  • 9.2.9 Bio-Rad Laboratories Inc
  • 9.2.10 Mission Bio Inc
  • 9.2.11 Standard BioTools Inc